leventa
schering-plough animal health limited - levothyroxine sodium pentahydrate - levothyroxine sodium pentahydrate 1 g/litre - endocrine agent (hormone)
baytril 25 flavour antibacterial oral suspension
elanco australasia pty ltd - enrofloxacin - oral solution/suspension - enrofloxacin antibiotic active 25.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | infections of the respiratory tract | infections of the urinary tracts | infectious sinusitis | staphylococcus intermedius | wound infections | abscesses | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | deep pyodermas | discharging sinuses | escherichia coli | gram negative organisms | gram positive organisms | group d streptococcus | including secondary invaders | klebsiella spp. | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | proteus spp. | pseudomonas aeruginosa | seborrhoeic dermatitis | staphylococcus spp. | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria
leventa 1 mg/ml or. sol.
intervet international b.v. - levothyroxine sodium 1 mg/ml - eq. levothyroxine 0,97 mg/ml - oral solution - 1 mg/ml - levothyroxine sodium 1 mg/ml - levothyroxine sodium - dog
bloatenz oral liquid bloat treatment and preventative
ecolab pty ltd - calcium, magnesium and potassium-salts of arabic acid - oral solution/suspension - calcium, magnesium and potassium-salts of arabic acid emulsifiers & surfactants active 969.0 g/l - alimentary system - cattle | trough | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bloat | water treatment/sanitiser | bloated | colic | frothy bloat | gas colic | legume bloat | weight gain
serenace 2 mg/ml oral solution
norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - oral solution - 2 mg/ml
leventa solution
intervet canada corp - levothyroxine sodium - solution - 1mg - levothyroxine sodium 1mg - dogs
penicillin v potassium tablet penicillin v potassium for solution
par pharmaceutical - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g- sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections (without bacteremia): mild-to-moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections : mild to moderately severe infections of the respiratory tract. staphylococcal infections - penicillin g sensi
carlevent levodopa/carbidopa/entacapone 150/37.5/200 mg tablet bottle
medis pharma pty ltd - carbidopa monohydrate, quantity: 40.5 mg (equivalent: carbidopa, qty 37.5 mg); entacapone, quantity: 200 mg; levodopa, quantity: 150 mg - tablet, film coated - excipient ingredients: trehalose dihydrate; hyprolose; magnesium stearate; microcrystalline cellulose; sodium sulfate; carmellose sodium; powdered cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.
carlevent levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle
medis pharma pty ltd - carbidopa monohydrate, quantity: 33.75 mg (equivalent: carbidopa, qty 31.25 mg); entacapone, quantity: 200 mg; levodopa, quantity: 125 mg - tablet, film coated - excipient ingredients: trehalose dihydrate; microcrystalline cellulose; hyprolose; magnesium stearate; powdered cellulose; carmellose sodium; sodium sulfate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.
carlevent levodopa/carbidopa/entacapone 100/25/200 mg tablet bottle
medis pharma pty ltd - entacapone, quantity: 200 mg; levodopa, quantity: 100 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, film coated - excipient ingredients: sodium sulfate; powdered cellulose; hyprolose; trehalose dihydrate; magnesium stearate; carmellose sodium; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.